Metropolis Healthcare Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Surendran Chemmenkotil
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 1.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | less than a year |
| Gemiddelde ambtstermijn bestuur | 5.3yrs |
Recente managementupdates
Recent updates
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 13
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 14Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next
May 24Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | n/a | n/a | ₹1b |
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹1b |
| Mar 31 2023 | ₹52m | ₹13m | ₹1b |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Surendran redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de Indian markt.
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Surendran te vergelijken met de prestaties van het bedrijf.
CEO
Surendran Chemmenkotil
1.8yrs
Tenure
₹52,318,552
Compensatie
Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairperson | 16.5yrs | ₹47.88m | 0.35% ₹ 367.5m | |
| Founder & Chairman Emeritus | no data | ₹18.00m | 18.44% ₹ 19.1b | |
| Chief Executive Officer | 1.8yrs | ₹52.32m | geen gegevens | |
| Interim Chief Financial Officer | no data | geen gegevens | geen gegevens | |
| Chief Operating Officer | no data | geen gegevens | geen gegevens | |
| Chief Scientific & Innovation Officer | no data | geen gegevens | geen gegevens | |
| Chief Information Officer | less than a year | geen gegevens | geen gegevens | |
| Head of Legal & Secretarial and Compliance Officer | less than a year | geen gegevens | geen gegevens | |
| Head of Public Relations & Corporate Communications | 3.2yrs | geen gegevens | geen gegevens | |
| Chief Marketing Officer | 1.3yrs | geen gegevens | geen gegevens | |
| Chief People Officer | 4.8yrs | geen gegevens | geen gegevens | |
| President of Internal Assurance & Advisor to CEO | no data | geen gegevens | geen gegevens |
1.0yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van METROPOLIS wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1 jaar), wat duidt op een nieuw team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairperson | 16.5yrs | ₹47.88m | 0.35% ₹ 367.5m | |
| Founder & Chairman Emeritus | 19.3yrs | ₹18.00m | 18.44% ₹ 19.1b | |
| Non-Executive Independent Director | 4.5yrs | ₹2.18m | geen gegevens | |
| Non-Executive Independent Director | 6.2yrs | ₹1.73m | geen gegevens | |
| Non-Executive Independent Director | 6.2yrs | ₹1.85m | 0.00028% ₹ 290.1k | |
| Independent Director | less than a year | ₹500.00k | geen gegevens | |
| Non-Executive Independent Director | 3.5yrs | geen gegevens | geen gegevens | |
| Non-Executive Director | less than a year | geen gegevens | geen gegevens |
5.3yrs
Gemiddelde duur
58.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van METROPOLIS wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).